绿康生化
(002868)
| 流通市值：23.13亿 | | | 总市值：23.51亿 |
| 流通股本：1.53亿 | | | 总股本：1.55亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 472,003,448.49 | 326,427,943.39 | 160,395,845.1 | 507,004,856.86 |
| 营业收入 | 472,003,448.49 | 326,427,943.39 | 160,395,845.1 | 507,004,856.86 |
| 二、营业总成本 | 614,888,371.22 | 413,562,190.13 | 188,466,936.22 | 676,873,889.1 |
| 营业成本 | 482,764,149.67 | 326,658,438.57 | 147,306,864.41 | 552,431,745.09 |
| 税金及附加 | 5,520,075.84 | 3,646,620.12 | 1,157,620.91 | 4,400,228.49 |
| 销售费用 | 11,130,840.35 | 8,111,405.57 | 3,678,182.46 | 15,926,283.19 |
| 管理费用 | 34,671,203.19 | 25,145,452.69 | 12,219,131.83 | 38,133,187.89 |
| 研发费用 | 30,014,022.67 | 19,147,738.8 | 7,835,076.19 | 27,530,726.83 |
| 财务费用 | 50,788,079.5 | 30,852,534.38 | 16,270,060.42 | 38,451,717.61 |
| 其中:利息费用 | 42,028,670.91 | 31,386,563.47 | 15,545,531.13 | 37,104,079.95 |
| 其中:利息收入 | 155,053.81 | 450,636.42 | 153,409.43 | 123,297.5 |
| 加:投资收益 | 12,789,946.9 | 11,919,596.09 | -62,958.87 | 11,430,565.6 |
| 资产处置收益 | 4,085,215.97 | 4,250,066.26 | - | -36,213.43 |
| 资产减值损失(新) | -66,786,072.89 | -48,056,604.83 | -9,856,699.02 | -79,243,938.97 |
| 信用减值损失(新) | 2,278,242.03 | 148,569.02 | -2,456,692.31 | -1,663,712.19 |
| 其他收益 | 3,102,701.66 | 1,932,424.02 | 885,865.73 | 3,250,431.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -187,414,889.06 | -116,940,196.18 | -39,561,575.59 | -236,131,900.13 |
| 加:营业外收入 | 195,824.56 | 190,177.88 | 0 | 431,048.62 |
| 减:营业外支出 | 122,829.7 | 107,829.17 | 56,337.85 | 5,192,603.17 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -187,341,894.2 | -116,857,847.47 | -39,617,913.44 | -240,893,454.68 |
| 减:所得税费用 | -29,783,784.46 | -29,144,090.28 | -8,044,692.92 | -18,276,357.86 |
| 六、净利润 | -157,558,109.74 | -87,713,757.19 | -31,573,220.52 | -222,617,096.82 |
| 持续经营净利润 | -157,558,109.74 | -87,713,757.19 | -31,573,220.52 | -222,617,096.82 |
| 归属于母公司股东的净利润 | -156,982,192.18 | -87,078,494.7 | -31,342,797.54 | -221,817,878.58 |
| 少数股东损益 | -575,917.56 | -635,262.49 | -230,422.98 | -799,218.24 |
| (一)基本每股收益 | -1.01 | -0.56 | -0.2 | -1.44 |
| (二)稀释每股收益 | -1.01 | -0.56 | -0.2 | -1.44 |
| 九、综合收益总额 | -157,558,109.74 | -87,713,757.19 | -31,573,220.52 | -222,617,096.82 |
| 归属于母公司股东的综合收益总额 | -156,982,192.18 | -87,078,494.7 | -31,342,797.54 | -221,817,878.58 |
| 归属于少数股东的综合收益总额 | -575,917.56 | -635,262.49 | -230,422.98 | -799,218.24 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |